AGENUS INC Revenues
AGENUS INC (AGEN) reported Revenues of $1.64 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-05-10
- AGENUS INC revenues for the quarter ending 2018-03-31 was $1.64M, a 93.93% decline year-over-year.
- AGENUS INC revenues for the quarter ending 2017-12-31 was $8.35M, a 49.82% increase year-over-year.
- AGENUS INC revenues for the quarter ending 2017-09-30 was $3.36M, a 24.45% decline year-over-year.
- AGENUS INC revenues for the quarter ending 2017-06-30 was $4.21M, a 36.17% decline year-over-year.
- AGENUS INC revenues for fiscal 2017 was $42.88M, a 89.95% increase from fiscal 2016.
- AGENUS INC revenues for fiscal 2016 was $22.57M, a 9.04% decline from fiscal 2015.
- AGENUS INC revenues for fiscal 2015 was $24.82M, a 255.67% increase from fiscal 2014.
- AGENUS INC revenues for fiscal 2014 was $6.98M, a 129.13% increase from fiscal 2013.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $1.64M 10-Q · filed 2018-05-10 | $9.99M derived: sum of 2 quarters · filed 2018-05-10 | $13.35M derived: sum of 3 quarters · filed 2018-05-10 | $17.56M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-12-31 | $8.35M 10-K · filed 2018-03-16 | $11.71M derived: sum of 2 quarters · filed 2018-03-16 | $15.92M derived: sum of 3 quarters · filed 2018-03-16 | $42.88M 10-K · filed 2018-03-16 | |
| 2017-09-30 | $3.36M 10-K · filed 2018-03-16 | $3.36M 10-Q · filed 2017-11-07 | $7.57M derived: sum of 2 quarters · filed 2018-03-16 | $34.52M 10-Q · filed 2017-11-07 | $40.10M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | $4.21M 10-K · filed 2018-03-16 | $4.21M 10-Q · filed 2017-08-07 | $31.16M 10-Q · filed 2017-08-07 | $36.74M derived: sum of 3 quarters · filed 2018-05-10 | $41.19M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | $26.96M 10-Q · filed 2018-05-10 | $32.53M derived: sum of 2 quarters · filed 2018-05-10 | $36.98M derived: sum of 3 quarters · filed 2018-05-10 | $43.57M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | $5.58M 10-K · filed 2018-03-16 | $10.02M derived: sum of 2 quarters · filed 2018-03-16 | $16.61M derived: sum of 3 quarters · filed 2018-03-16 | $22.57M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $4.45M 10-K · filed 2018-03-16 | $4.45M 10-Q · filed 2016-11-09 | $11.04M derived: sum of 2 quarters · filed 2018-03-16 | $17.00M 10-Q · filed 2017-11-07 | $24.64M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $6.59M 10-K · filed 2018-03-16 | $6.59M 10-Q · filed 2016-08-04 | $12.55M 10-Q · filed 2017-08-07 | $20.19M derived: sum of 3 quarters · filed 2018-03-16 | $27.04M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $5.96M 10-K · filed 2018-03-16 | $5.96M 10-Q · filed 2016-05-09 | $13.60M derived: sum of 2 quarters · filed 2018-03-16 | $20.45M derived: sum of 3 quarters · filed 2018-03-16 | $26.82M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $7.64M 10-K · filed 2017-03-16 | $14.49M derived: sum of 2 quarters · filed 2017-03-16 | $20.86M derived: sum of 3 quarters · filed 2017-03-16 | $24.82M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $6.85M 10-K · filed 2017-03-16 | $6.85M 10-Q · filed 2015-11-04 | $13.22M derived: sum of 2 quarters · filed 2017-03-16 | $17.18M 10-Q · filed 2016-11-09 | $18.80M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $6.38M 10-K · filed 2017-03-16 | $6.38M 10-Q · filed 2015-08-03 | $10.33M 10-Q · filed 2016-08-04 | $11.95M derived: sum of 3 quarters · filed 2017-03-16 | $13.51M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $3.95M 10-K · filed 2017-03-16 | $3.95M 10-Q · filed 2015-05-01 | $5.57M derived: sum of 2 quarters · filed 2017-03-16 | $7.13M derived: sum of 3 quarters · filed 2017-03-16 | $10.21M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $1.62M 10-K · filed 2016-03-15 | $3.18M derived: sum of 2 quarters · filed 2016-03-15 | $6.26M derived: sum of 3 quarters · filed 2016-03-15 | $6.98M 10-K · filed 2017-03-16 | |
| 2014-09-30 | $1.56M 10-K · filed 2016-03-15 | $1.56M 10-Q · filed 2014-10-31 | $4.64M derived: sum of 2 quarters · filed 2016-03-15 | $5.36M 10-Q · filed 2015-11-04 | $5.75M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $3.07M 10-K · filed 2016-03-15 | $3.07M 10-Q · filed 2014-08-01 | $3.79M 10-Q · filed 2015-08-03 | $4.19M derived: sum of 3 quarters · filed 2016-03-15 | $4.92M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $721.00K 10-K · filed 2016-03-15 | $720.86K 10-Q · filed 2014-05-09 | $1.11M derived: sum of 2 quarters · filed 2016-03-15 | $1.85M derived: sum of 3 quarters · filed 2016-03-15 | $2.66M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $393.00K 10-K · filed 2015-03-16 | $1.13M derived: sum of 2 quarters · filed 2015-03-16 | $1.94M derived: sum of 3 quarters · filed 2015-03-16 | $3.05M 10-K · filed 2016-03-15 | |
| 2013-09-30 | $736.00K 10-K · filed 2015-03-16 | $735.99K 10-Q · filed 2013-11-08 | $1.54M derived: sum of 2 quarters · filed 2015-03-16 | $2.65M 10-Q · filed 2014-10-31 | $3.74M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $807.00K 10-K · filed 2015-03-16 | $807.40K 10-Q · filed 2013-08-09 | $1.92M 10-Q · filed 2014-08-01 | $3.01M derived: sum of 3 quarters · filed 2015-03-16 | $3.88M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $1.11M 10-K · filed 2015-03-16 | $1.11M 10-Q · filed 2013-05-10 | $2.20M derived: sum of 2 quarters · filed 2015-03-16 | $3.07M derived: sum of 3 quarters · filed 2015-03-16 | $3.69M derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $1.09M 10-K · filed 2014-03-07 | $1.96M derived: sum of 2 quarters · filed 2014-03-07 | $2.59M derived: sum of 3 quarters · filed 2014-03-07 | $15.96M 10-K · filed 2015-03-16 | |
| 2012-09-30 | $869.00K 10-K · filed 2014-03-07 | $868.80K 10-Q · filed 2012-11-07 | $1.50M derived: sum of 2 quarters · filed 2014-03-07 | $14.87M 10-Q · filed 2013-11-08 | $15.52M derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | $627.00K 10-K · filed 2014-03-07 | $626.79K 10-Q · filed 2012-08-08 | $14.00M 10-Q · filed 2013-08-09 | $14.65M derived: sum of 3 quarters · filed 2014-03-07 | $15.30M derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | $13.38M 10-K · filed 2014-03-07 | $13.37M 10-Q · filed 2012-05-09 | $14.02M derived: sum of 2 quarters · filed 2014-03-07 | $14.67M derived: sum of 3 quarters · filed 2014-03-07 | $15.46M derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | $644.00K 10-K · filed 2013-03-18 | $1.30M derived: sum of 2 quarters · filed 2013-03-18 | $2.08M derived: sum of 3 quarters · filed 2013-03-18 | $2.76M 10-K · filed 2014-03-07 | |
| 2011-09-30 | $654.00K 10-K · filed 2013-03-18 | $653.68K 10-Q · filed 2011-11-04 | $1.44M derived: sum of 2 quarters · filed 2013-03-18 | $2.11M 10-Q · filed 2012-11-07 | $3.11M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $786.00K 10-K · filed 2013-03-18 | $786.43K 10-Q · filed 2011-08-05 | $1.46M 10-Q · filed 2012-08-08 | $2.45M derived: sum of 3 quarters · filed 2013-03-18 | $3.08M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $672.00K 10-K · filed 2013-03-18 | $671.88K 10-Q · filed 2012-05-09 | $1.67M derived: sum of 2 quarters · filed 2013-03-18 | $2.29M derived: sum of 3 quarters · filed 2013-03-18 | $3.10M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $993.56K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.62M derived: sum of 2 quarters · filed 2013-03-18 | $2.42M derived: sum of 3 quarters · filed 2013-03-18 | $3.36M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $624.45K 10-Q · filed 2011-11-04 | $1.43M derived: sum of 2 quarters · filed 2011-11-04 | $2.37M 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $805.17K 10-Q · filed 2011-08-05 | $1.74M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $3.33M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |